Regulatory Top Stories Bone Biologics Files Patent Application for Bone Regeneration Technology byJosh SandbergJune 27, 2025
Biologics Spine Top Stories Bone Biologics Appoints Phillip T. Meikle to its Board of Directors byJosh SandbergOctober 21, 2024
Financial Spine Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds byTim AllenAugust 2, 2024
Financial Bone Biologics Announces Closing of $2.0 Million Public Offering byJosh SandbergMarch 6, 2024
Financial Bone Biologics Announces Pricing of $2.0 Million Public Offering byJosh SandbergMarch 4, 2024
Biologics Spine Bone Biologics Reports Progress With NB1 Clinical Program byJosh SandbergMarch 1, 2024
Biologics Financial Spine Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors byJosh SandbergJanuary 11, 2024